Rockwell Medical (RMTI) Cash from Operations (2010 - 2026)

Rockwell Medical (RMTI) has reported Cash from Operations for 17 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Operations rose 14.59% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2026 stood at $2.9 million (down 18.33% YoY), and the FY2025 full-year result was -$700000.0, down 116.66% from the prior year.
• Cash from Operations grew to $2.1 million in Q2 2026 per RMTI's latest filing, from -$200000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at $4.3 million in Q3 2024 and bottomed at -$9.8 million in Q1 2022.
• Historically, Cash from Operations has averaged -$1.2 million across 5 years, with a median of -$651000.0 in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations plunged 240.56% in 2023, then jumped 2111.63% in 2024.
• Over 5 years, Cash from Operations stood at -$112000.0 in 2022, then soared by 61.61% to -$43000.0 in 2023, then surged by 2111.63% to $865000.0 in 2024, then surged by 165.9% to $2.3 million in 2025, then fell by 8.13% to $2.1 million in 2026.
• According to Business Quant data, Cash from Operations over the past three periods registered $2.1 million, -$200000.0, and $2.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.